You are here

Medical Device Tax

The U.S. leads the world in medical technology innovation. The medical device excise tax, a 2.3% levy, threatens to stifle American innovation and hinder the ability of industry to develop new life-saving and life-enhancing medical devices. Initially implemented in 2013 as part of the Affordable Care Act, the tax has been suspended twice because policymakers recognized the tax for what it is -- bad policy that will harm patients, health care providers, and the American economy. 

If Congress fails to act, the device tax will be reinstated in January 2020. Congress must end the tax once and for all to save and improve patients’ lives and to encourage job growth and innovation. Only with long-term tax relief will the medtech industry be able to make the multi-year investments in R&D and infrastructure necessary to sustain this dynamic innovation ecosystem.

Tell Congress to end the device tax. (link is external)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tracking Device Tax Support

For members only:

View our interactive tool tracking support for repeal of the Medical Device Tax in both the House and Senate.

Related Links